IMMULITE 2000 XPI ANTI-HBC
FDA premarket approval P010051 · decided 2002-07-24
Approval details
- PMA number
- P010051
- Trade name
- IMMULITE 2000 XPI ANTI-HBC
- Generic name
- Qualitative and Quantitative Hepatitis B Virus Antibody assays
- Applicant
- Siemens Healthcare Diagnostics Products, Ltd.
- Date received
- 2001-08-31
- Decision date
- 2002-07-24
- Days to decision
- 327 days
- Decision code
- APRL
- Product code
- SEI
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- Llanberis
- Statement
- APPROVAL FOR THE IMMULITE ANTI-HBC AND IMMULITE 2000 ANTI-HBC. THESE DEVICES ARE INDICATED FOR: IMMULITE. ANTI-HBC: IMMULITE ANTI-HBC IS A SOLID -PHASE CHEMILUMINESCENT ENZYME IMMUNOASSAY DESIGNED FOR USE ON THE IMMULITE AUTOMATED IMMUNOASSAY ANALYZER FOR THE QUALITATIVE DETECTION OF TOTAL ANTIBODIES AGAINST HEPATITIS B CORE ANTIGEN (ANTI-HBC) IN HUMAN SERUM OR PLASMA (EDTA, HEPARINIZED, CITRATE). IT IS INTENDED FOR IN VITRO DIAGNOSTIC USE FOR THE LABORATORY DIAGNOSIS OF ONGOING OR PREVIOUS HEPA
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| IMMULITE® 2000 BR-MA (K233946) | Siemens Healthcare Diagnostics Products, Ltd. | 2024-03-13 |
| IMMULITE/IMMULITE 1000 OM-MA, IMMULITE 2000 OM-MA (K213510) | Siemens Healthcare Diagnostics Products, Ltd. | 2023-09-08 |
| IMMULITE® 2000 Cortisol (K202826) | Siemens Healthcare Diagnostics Products, Ltd. | 2021-01-15 |
| IMMULITE/IMMULITE® 1000 Cortisol (K203270) | Siemens Healthcare Diagnostics Products, Ltd. | 2021-01-15 |